$ENVA

Fisher David sold $4.5M of ENVA

Fisher David (Executive Chairman) sold 18,569 shares of Enova International, Inc. (ENVA) at an average of $241.64 ($239.16–$244.01, $4.49M total) across 2 trades over 2026-08-25 to 2026-08-26 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Fisher David
Published Aug 27, 2026, 8:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 27, 2026, 9:00 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ENVA
Bearish
high confidence
Mentioned
$ENVA
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ENVABearishMed
01

Why it matters

The disclosed sale adds new information about insider sentiment, which can influence short‑term price action.

02

Market read

New insider sale provides fresh data for traders; may prompt short‑term sell pressure.

03

What to watch

The 10b5-1 plan may have been set before any material news, and the remaining stake remains sizable.

Relevance 5/10Novelty 7/10Timing: after market on 2026-08-27

Background

SEC Form 4 filings disclose insider transactions; a sale by an executive chairman is closely watched by market participants.

Company-level read

Ticker impact

$ENVABearishHigh confidence
Context

Executive Chairman Fisher David sold 18,569 shares for $4.5M via a 10b5-1 plan, reducing his stake to 306,444 shares.

Expected impact

Potential modest downside of 2-4% over the next few days.

Evidence & confidence

Large insider sale by a top executive, disclosed on Form 4, is a material new fact that traders often view as a bearish signal.

Market effects

Minimal; the sale is company‑specific and does not affect the broader fintech sector.

None; the filing is U.S. focused.

Low; only relevant to ENVA investors.

Counterpoint

The sale could be a routine liquidity event under a pre‑arranged plan, not necessarily a lack of confidence.

Key entities

  • Enova International, Inc.

    US‑listed fintech lender (ticker ENVA).

  • Fisher David

    Executive Chairman of Enova International.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ENVAMedAI 8/10

Enova International subsidiary announces $500 million asset-backed notes offering

Enova International's subsidiary plans a $500M asset-backed notes offering, with four classes of notes ranging from 5.61% to 8.28% interest. The notes are backed by small business loans and expected to be rated by Kroll. Enova reported strong Q2 2026 earnings, exceeding estimates, but withdrew a bank acquisition due to regulatory challenges. Citizens lowered its price target to $215, maintaining an Outperform rating.

$ENVAMedAI 8/10

Enova to issue $500.026M Series 2026-1 asset-backed notes backed by OnDeck loans

Enova plans to issue $500.026M in asset-backed notes due 2026, secured by OnDeck small business loans. The notes, divided into four classes, have fixed rates ranging from 5.61% to 8.28%. KBRA is expected to rate the notes AA(sf) to BB(sf). The proceeds will be used to purchase loans from OnDeck and fund a reserve account. The offering is targeted at qualified institutional buyers under Rule 144A and offshore under Regulation S, with a closing date around September 25, 2026, subject to conditions